Brexpiprazole has a low risk of dopamine D<sub>2</sub> receptor sensitization and inhibits rebound phenomena related to D<sub>2</sub> and serotonin 5‐HT<sub>2A</sub> receptors in rats - Concepedia

Concepedia

Publication | Open Access

Brexpiprazole has a low risk of dopamine D<sub>2</sub> receptor sensitization and inhibits rebound phenomena related to D<sub>2</sub> and serotonin 5‐HT<sub>2A</sub> receptors in rats

DOI Full Paper Access

24

Citations

44

References

2019

Year

Naoki Amada, Hitomi Akazawa, Yuta Ohgi, Kenji Maeda, Haruhiko Sugino, Nobuyuki Kurahashi, Tetsuro Kikuchi, Takashi Futamura

Neuropsychopharmacology Reports

Abstract

Brexpiprazole has a low risk of D<sub>2</sub> receptor sensitization after a repeated administration and suppresses the rebound phenomena related to D<sub>2</sub> and 5-HT<sub>2A</sub> receptors after a repeated administration of risperidone.

References

	Year	Citations

Page 1